当前位置:药药网 / 数据中心 / 儿科研究特征电子表格
AirDuo RespiClick; AirDuo Digihaler inhalation powder
通用名称
fluticasone propionate/salmeterol xinafoate
儿科标签批准日期
2021/7/9 0:00:00
标签更改摘要
- Safety and effectiveness have not been established in pediatric patients younger than 12 years of age for the treatment of asthma.
- Effectiveness was not demonstrated in one adequate and well-controlled study conducted in 211 patients aged 4 to 11 years with persistent asthma.
- Postmarketing study.